| Place of Origin: | Shaanxi, China |
|---|---|
| Brand Name: | Ceres |
| Certification: | ISO9001,GMP |
| Model Number: | 99% |
| Minimum Order Quantity: | 1kg |
| Price: | $80-100 kg |
| Packaging Details: | Drum, Vacuum Packed, Aluminium Foil Bag |
| Payment Terms: | T/T, Western Union, L/C, MoneyGram, D/A, D/P |
| Supply Ability: | 5000 Kilogram/Kilograms per Month |
| Producr Name: | Gliclazide | Grade: | Pharmaceutical Grade |
|---|---|---|---|
| Free Sample: | Available | COA: | Available |
| Apply For: | Health Care | Shelf Life: | 2 Year When Properly Stored |
| Color: | White | Packaging: | Drum, Vacuum Packed, Aluminium Foil Bag |
| High Light: | Gliclazide White Crystalline Powder,API White Crystalline Powder,CAS 21187-98-4 API Raw Material |
||
Gliclazide is a second-generation sulfonylurea oral hypoglycemic drug with dual effects of lowering blood sugar and improving blood coagulation. It can not only improve the metabolism of diabetic patients, but also improve or delay the occurrence of diabetic vascular complications.
1. Hypoglycemic effect: This product is a second-generation oral sulfonylurea hypoglycemic agent, and its effect is more than 10 times stronger than that of tolbutamide. The mechanism of action is to stimulate the release of insulin from islet β cells, which reduces hyperglycemia. This may be due to the fact that sulfonylureas bind to receptors on the surface of β cells and increase their activation and simultaneously improve the sensitivity of peripheral target tissues to insulin.
2. Reduce platelet aggregation and adhesion, prevent fibrin deposition on microvessels.
3. Reduces cholesterol accumulation and reduces arterial plasma concentrations of glycerol triphosphate and fatty acids.
The three functions, in addition to the treatment of diabetic metabolic disorders, can also prevent and treat the occurrence and development of diabetic complications - vascular, retinal, and renal dysfunction.
